Image

Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area

Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomotic Leaks (AL) or Hartmann's stump leakages following colorectal surgery in a prospective multi-center study.

Eligibility

Inclusion Criteria:

  • Confirmed grade B anastomotic leak as per the ISGRC (International Study Group of Rectal Cancer) grading system after colorectal surgery.
  • Subject is eligible for endoscopic intervention.
  • Subject has a transmural defect of at least 2 cm in diameter following colorectal surgery in the lower pelvic area.
  • Subject has an anastomotic or Hartmann's stump leak located within an extraperitoneal cavity.
  • Subject has pre-existing diverting ostomy or an ostomy created prior to the first Endo-SPONGE placement.
  • Subject understands the trial requirements and is willing and able to comply with the study procedures, all protocol-required follow up evaluations and provide written informed consent to participate in the study.
  • Investigator decision that EVT is the most suitable treatment of the available treatment options.

Exclusion Criteria:

  • Subject is under 18 years of age.
  • Potentially vulnerable subject, including, but not limited to pregnant women.
  • Subject has undergone EVT or other similar interventions for the current colorectal indication.
  • Subject had colorectal surgery more than 60 days prior to the planned study procedure.
  • Subject has any necrotic tissue that would require endoscopic debridement prior to Endo-SPONGE placement.
  • Subject has known contraindication for EVT as per the IB.
  • Subject is currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor.

Study details
    Anastomotic Leaks
    Hartmanns Stump Leakage

NCT07035431

Boston Scientific Corporation

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.